Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT05159167
Eligibility Criteria:
Inclusion Criteria:
* This trial aims to enroll 18- to 75-year-old patients expected to survive \> 3 months and with a Zubrod performance status of 0 to 2. All patients must have diagnosed as lung cancer and have at least one cycle of adjuvant chemotherapy. Enrolled patients should have a minimal ESAS fatigue as 3. Other inclusion criteria are lack of leptomeningeal disease, adequate hepatorenal function and blood counts (red blood cells, \>3.0 \* 1012/L; white blood cells, \> 3.5 \* 109/L; absolute neutrophil count, \> 1.5 \* 109/L; platelets, \> 100 \* 109/L; hemoglobin \> 90 g/L).
Exclusion Criteria:
* Children
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05159167
Study Brief:
Protocol Section:
NCT05159167